Related Experiment Video

Updated: May 27, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

The expanding relevance of nuclear mTOR in carcinogenesis

Jung H Back1, Arianna L Kim

  • 1Department of Dermatology, Columbia University Medical Center, New York, NY, USA.

Cell Cycle (Georgetown, Tex.)
|November 10, 2011
PubMed

Insights

Dysregulated mTOR signaling fuels cancer growth, with new research revealing its nuclear functions beyond the cytoplasm. Understanding these nuclear roles is key to developing novel cancer chemotherapeutics targeting mTOR.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Deregulation of mTOR signaling is a key driver in human cancers.
  • mTOR's role in cancer has been primarily attributed to its cytoplasmic functions, promoting gene translation.
  • Emerging evidence indicates mTOR localization and function within various subcellular compartments.

Purpose of the Study:

  • To explore the non-cytoplasmic roles of mTOR in carcinogenesis.
  • To identify mTOR substrates in distinct subcellular locations.
  • To elucidate mechanisms of mTOR substrate recruitment and downstream effects in different compartments.

Main Methods:

  • Investigating mTOR localization in subcellular compartments (Golgi, mitochondria, ER, nucleus).
  • Identifying compartment-specific mTOR substrates.
  • Analyzing the functional consequences of mTOR activity in these compartments.

Main Results:

  • mTOR is present in multiple subcellular compartments, including the nucleus.
  • Compartment-specific substrates and functions of mTOR are implied.
  • Further research is needed to fully characterize these novel roles.

Conclusions:

  • mTOR's function extends beyond the cytoplasm, with significant implications in other subcellular locations.
  • Understanding nuclear and other compartment-specific mTOR activities is crucial for cancer therapy.
  • Identifying novel mTOR substrates and mechanisms will enhance our understanding of mTOR's diverse roles in cancer.

More Related Videos

Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...